Oncology Biomarker Market, Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: OF56461EF20BEN
Market Monitor Global

Abstracts

A biomarker is referred to as a traceable biomolecule, whose presence found in body fluids such as blood, serum, urine, and tumor fluid that indicates disease or an underlying condition such as cancer.

This report contains market size and forecasts of Oncology Biomarker in Global, including the following market information:

Global Oncology Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Oncology Biomarker market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lung Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oncology Biomarker include Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., Genomic Health, GlaxoSmithKline plc, Novartis AG, Merck & Co. and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oncology Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Oncology Biomarker Market Segment Percentages, by Type, 2021 (%)

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Stomach Cancer
• Others

Global Oncology Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Oncology Biomarker Market Segment Percentages, by Application, 2021 (%)

• Diagnostics
• Drug Discovery And Development
• Prognostics
• Risk Assessment
• Others

Global Oncology Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Oncology Biomarker Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oncology Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Oncology Biomarker revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Bristol-Myers Squibb
• Eli Lilly and Company
• F.Hoffmann-La Roche Ltd.
• Genomic Health
• GlaxoSmithKline plc
• Novartis AG
• Merck & Co.
• Pfizer
• Qiagen N.V.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oncology Biomarker Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oncology Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ONCOLOGY BIOMARKER OVERALL MARKET SIZE

2.1 Global Oncology Biomarker Market Size: 2021 VS 2028
2.2 Global Oncology Biomarker Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oncology Biomarker Players in Global Market
3.2 Top Global Oncology Biomarker Companies Ranked by Revenue
3.3 Global Oncology Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Oncology Biomarker Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oncology Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Biomarker Players in Global Market
  3.6.1 List of Global Tier 1 Oncology Biomarker Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oncology Biomarker Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Oncology Biomarker Market Size Markets, 2021 & 2028
  4.1.2 Lung Cancer
  4.1.3 Breast Cancer
  4.1.4 Colorectal Cancer
  4.1.5 Prostate Cancer
  4.1.6 Stomach Cancer
  4.1.7 Others
4.2 By Type - Global Oncology Biomarker Revenue & Forecasts
  4.2.1 By Type - Global Oncology Biomarker Revenue, 2017-2022
  4.2.2 By Type - Global Oncology Biomarker Revenue, 2023-2028
  4.2.3 By Type - Global Oncology Biomarker Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oncology Biomarker Market Size, 2021 & 2028
  5.1.2 Diagnostics
  5.1.3 Drug Discovery And Development
  5.1.4 Prognostics
  5.1.5 Risk Assessment
  5.1.6 Others
5.2 By Application - Global Oncology Biomarker Revenue & Forecasts
  5.2.1 By Application - Global Oncology Biomarker Revenue, 2017-2022
  5.2.2 By Application - Global Oncology Biomarker Revenue, 2023-2028
  5.2.3 By Application - Global Oncology Biomarker Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oncology Biomarker Market Size, 2021 & 2028
6.2 By Region - Global Oncology Biomarker Revenue & Forecasts
  6.2.1 By Region - Global Oncology Biomarker Revenue, 2017-2022
  6.2.2 By Region - Global Oncology Biomarker Revenue, 2023-2028
  6.2.3 By Region - Global Oncology Biomarker Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Oncology Biomarker Revenue, 2017-2028
  6.3.2 US Oncology Biomarker Market Size, 2017-2028
  6.3.3 Canada Oncology Biomarker Market Size, 2017-2028
  6.3.4 Mexico Oncology Biomarker Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Oncology Biomarker Revenue, 2017-2028
  6.4.2 Germany Oncology Biomarker Market Size, 2017-2028
  6.4.3 France Oncology Biomarker Market Size, 2017-2028
  6.4.4 U.K. Oncology Biomarker Market Size, 2017-2028
  6.4.5 Italy Oncology Biomarker Market Size, 2017-2028
  6.4.6 Russia Oncology Biomarker Market Size, 2017-2028
  6.4.7 Nordic Countries Oncology Biomarker Market Size, 2017-2028
  6.4.8 Benelux Oncology Biomarker Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Oncology Biomarker Revenue, 2017-2028
  6.5.2 China Oncology Biomarker Market Size, 2017-2028
  6.5.3 Japan Oncology Biomarker Market Size, 2017-2028
  6.5.4 South Korea Oncology Biomarker Market Size, 2017-2028
  6.5.5 Southeast Asia Oncology Biomarker Market Size, 2017-2028
  6.5.6 India Oncology Biomarker Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Oncology Biomarker Revenue, 2017-2028
  6.6.2 Brazil Oncology Biomarker Market Size, 2017-2028
  6.6.3 Argentina Oncology Biomarker Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oncology Biomarker Revenue, 2017-2028
  6.7.2 Turkey Oncology Biomarker Market Size, 2017-2028
  6.7.3 Israel Oncology Biomarker Market Size, 2017-2028
  6.7.4 Saudi Arabia Oncology Biomarker Market Size, 2017-2028
  6.7.5 UAE Oncology Biomarker Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Oncology Biomarker Major Product Offerings
  7.1.4 Abbott Laboratories Oncology Biomarker Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Oncology Biomarker Major Product Offerings
  7.2.4 Bristol-Myers Squibb Oncology Biomarker Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Eli Lilly and Company
  7.3.1 Eli Lilly and Company Corporate Summary
  7.3.2 Eli Lilly and Company Business Overview
  7.3.3 Eli Lilly and Company Oncology Biomarker Major Product Offerings
  7.3.4 Eli Lilly and Company Oncology Biomarker Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly and Company Key News
7.4 F.Hoffmann-La Roche Ltd.
  7.4.1 F.Hoffmann-La Roche Ltd. Corporate Summary
  7.4.2 F.Hoffmann-La Roche Ltd. Business Overview
  7.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Major Product Offerings
  7.4.4 F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue in Global Market (2017-2022)
  7.4.5 F.Hoffmann-La Roche Ltd. Key News
7.5 Genomic Health
  7.5.1 Genomic Health Corporate Summary
  7.5.2 Genomic Health Business Overview
  7.5.3 Genomic Health Oncology Biomarker Major Product Offerings
  7.5.4 Genomic Health Oncology Biomarker Revenue in Global Market (2017-2022)
  7.5.5 Genomic Health Key News
7.6 GlaxoSmithKline plc
  7.6.1 GlaxoSmithKline plc Corporate Summary
  7.6.2 GlaxoSmithKline plc Business Overview
  7.6.3 GlaxoSmithKline plc Oncology Biomarker Major Product Offerings
  7.6.4 GlaxoSmithKline plc Oncology Biomarker Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline plc Key News
7.7 Novartis AG
  7.7.1 Novartis AG Corporate Summary
  7.7.2 Novartis AG Business Overview
  7.7.3 Novartis AG Oncology Biomarker Major Product Offerings
  7.7.4 Novartis AG Oncology Biomarker Revenue in Global Market (2017-2022)
  7.7.5 Novartis AG Key News
7.8 Merck & Co.
  7.8.1 Merck & Co. Corporate Summary
  7.8.2 Merck & Co. Business Overview
  7.8.3 Merck & Co. Oncology Biomarker Major Product Offerings
  7.8.4 Merck & Co. Oncology Biomarker Revenue in Global Market (2017-2022)
  7.8.5 Merck & Co. Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Oncology Biomarker Major Product Offerings
  7.9.4 Pfizer Oncology Biomarker Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 Qiagen N.V.
  7.10.1 Qiagen N.V. Corporate Summary
  7.10.2 Qiagen N.V. Business Overview
  7.10.3 Qiagen N.V. Oncology Biomarker Major Product Offerings
  7.10.4 Qiagen N.V. Oncology Biomarker Revenue in Global Market (2017-2022)
  7.10.5 Qiagen N.V. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oncology Biomarker Market Opportunities & Trends in Global Market
Table 2. Oncology Biomarker Market Drivers in Global Market
Table 3. Oncology Biomarker Market Restraints in Global Market
Table 4. Key Players of Oncology Biomarker in Global Market
Table 5. Top Oncology Biomarker Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oncology Biomarker Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oncology Biomarker Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oncology Biomarker Product Type
Table 9. List of Global Tier 1 Oncology Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oncology Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oncology Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oncology Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Oncology Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oncology Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oncology Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Oncology Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oncology Biomarker Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oncology Biomarker Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oncology Biomarker Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oncology Biomarker Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oncology Biomarker Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oncology Biomarker Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oncology Biomarker Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oncology Biomarker Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oncology Biomarker Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oncology Biomarker Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oncology Biomarker Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oncology Biomarker Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Oncology Biomarker Product Offerings
Table 32. Abbott Laboratories Oncology Biomarker Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Oncology Biomarker Product Offerings
Table 35. Bristol-Myers Squibb Oncology Biomarker Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly and Company Corporate Summary
Table 37. Eli Lilly and Company Oncology Biomarker Product Offerings
Table 38. Eli Lilly and Company Oncology Biomarker Revenue (US$, Mn), (2017-2022)
Table 39. F.Hoffmann-La Roche Ltd. Corporate Summary
Table 40. F.Hoffmann-La Roche Ltd. Oncology Biomarker Product Offerings
Table 41. F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue (US$, Mn), (2017-2022)
Table 42. Genomic Health Corporate Summary
Table 43. Genomic Health Oncology Biomarker Product Offerings
Table 44. Genomic Health Oncology Biomarker Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline plc Corporate Summary
Table 46. GlaxoSmithKline plc Oncology Biomarker Product Offerings
Table 47. GlaxoSmithKline plc Oncology Biomarker Revenue (US$, Mn), (2017-2022)
Table 48. Novartis AG Corporate Summary
Table 49. Novartis AG Oncology Biomarker Product Offerings
Table 50. Novartis AG Oncology Biomarker Revenue (US$, Mn), (2017-2022)
Table 51. Merck & Co. Corporate Summary
Table 52. Merck & Co. Oncology Biomarker Product Offerings
Table 53. Merck & Co. Oncology Biomarker Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Oncology Biomarker Product Offerings
Table 56. Pfizer Oncology Biomarker Revenue (US$, Mn), (2017-2022)
Table 57. Qiagen N.V. Corporate Summary
Table 58. Qiagen N.V. Oncology Biomarker Product Offerings
Table 59. Qiagen N.V. Oncology Biomarker Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Oncology Biomarker Segment by Type in 2021
Figure 2. Oncology Biomarker Segment by Application in 2021
Figure 3. Global Oncology Biomarker Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oncology Biomarker Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oncology Biomarker Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Biomarker Revenue in 2021
Figure 8. By Type - Global Oncology Biomarker Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oncology Biomarker Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oncology Biomarker Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oncology Biomarker Revenue Market Share, 2017-2028
Figure 12. US Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oncology Biomarker Revenue Market Share, 2017-2028
Figure 16. Germany Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 17. France Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oncology Biomarker Revenue Market Share, 2017-2028
Figure 24. China Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 28. India Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oncology Biomarker Revenue Market Share, 2017-2028
Figure 30. Brazil Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oncology Biomarker Revenue Market Share, 2017-2028
Figure 33. Turkey Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oncology Biomarker Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly and Company Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genomic Health Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline plc Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis AG Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck & Co. Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Qiagen N.V. Oncology Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)